CARBOLITH
CARBOLITH
Approved
DIN Number
00461733
Drug Class
Human
Market Date
Dec 31, 1979
Company
HC
bausch health, canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00461733
AIG Number0101163001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AN01 LITHIUM
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:28.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
LITHIUM CARBONATEActive
Strength: 150 MG
Monograph: LITHIUM CARBONATE